Clinical Trial Update: Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase feasibility study (PULSAR) evaluating personalized ultra-fractionated stereotactic ablative radiotherapy for central lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cancer, Lung, Metastasis | EARLY_Phase 1 | Status: RECRUITING